Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial

NCT02476279 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT02476279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02476279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis: The SVI Trial
Lead sponsor
Medical University of South Carolina
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2015
Completion date
January 25, 2023
Enrollment
1,950 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp pancreatitis